Triclosan-resistant small-colony variants of Staphylococcus aureus produce less capsule, less phenol-soluble modulins, and are attenuated in a Galleria mellonella model of infection

References

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520–532 [View Article] [PubMed]
   [Google Scholar]
2. Somerville GA, Proctor RA. At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci. Microbiol Mol Biol Rev 2009; 73:233–248 [View Article] [PubMed]
   [Google Scholar]
3. Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 2004; 40:1–9 [View Article] [PubMed]
   [Google Scholar]
4. Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence 2021; 12:547–569 [View Article] [PubMed]
   [Google Scholar]
5. O’Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 2004; 17:218–234 [View Article] [PubMed]
   [Google Scholar]
6. Thakker M, Park JS, Carey V, Lee JC. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infect Immun 1998; 66:5183–5189 [View Article] [PubMed]
   [Google Scholar]
7. Karakawa WW, Sutton A, Schneerson R, Karpas A, Vann WF. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun 1988; 56:1090–1095 [View Article] [PubMed]
   [Google Scholar]
8. Peterson PK, Wilkinson BJ, Kim Y, Schmeling D, Quie PG. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun 1978; 19:943–949 [View Article] [PubMed]
   [Google Scholar]
9. van Wamel W, Xiong Y-Q, Bayer AS, Yeaman MR, Nast CC et al. Regulation of Staphylococcus aureus type 5 capsular polysaccharides by agr and sarA in vitro and in an experimental endocarditis model. Microb Pathog 2002; 33:73–79 [View Article] [PubMed]
   [Google Scholar]
10. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46 Suppl 5:S350–9 [View Article]
    [Google Scholar]
11. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006; 4:295–305 [View Article] [PubMed]
    [Google Scholar]
12. Tuchscherr L, Löffler B, Proctor RA. Persistence of Staphylococcus aureus: multiple metabolic pathways impact the expression of virulence factors in small-colony variants (SCVs). Front Microbiol 2020; 11:1028 [View Article] [PubMed]
    [Google Scholar]
13. Edwards AM. Phenotype switching is a natural consequence of Staphylococcus aureus replication. J Bacteriol 2012; 194:5404–5412 [View Article] [PubMed]
    [Google Scholar]
14. Kipp F, Kahl BC, Becker K, Baron EJ, Proctor RA et al. Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small-colony variants. J Clin Microbiol 2005; 43:1956–1959 [View Article] [PubMed]
    [Google Scholar]
15. Latimer J, Forbes S, McBain AJ. Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan. Antimicrob Agents Chemother 2012; 56:3092–3100 [View Article] [PubMed]
    [Google Scholar]
16. Schleimer N, Kaspar U, Drescher M, Seggewiß J, von Eiff C et al. The energy-coupling factor transporter module EcfAA’T, a novel candidate for the genetic basis of fatty acid-auxotrophic small-colony variants of Staphylococcus aureus. Front Microbiol 2018; 9:9 [View Article] [PubMed]
    [Google Scholar]
17. Bayston R, Ashraf W, Smith T. Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics. J Antimicrob Chemother 2007; 59:848–853 [View Article] [PubMed]
    [Google Scholar]
18. Bazaid AS, Forbes S, Humphreys GJ, Ledder RG, O’Cualain R et al. Fatty acid supplementation reverses the small colony variant phenotype in triclosan-adapted Staphylococcus aureus: genetic, proteomic and phenotypic analyses. Sci Rep 2018; 8:3876 [View Article] [PubMed]
    [Google Scholar]
19. Schleimer N, Kaspar U, Drescher M, Seggewiß J, von Eiff C et al. The energy-coupling factor transporter module EcfAA’T, a novel candidate for the genetic basis of fatty acid-auxotrophic small-colony variants of Staphylococcus aureus. Front Microbiol 2018; 9:1863 [View Article] [PubMed]
    [Google Scholar]
20. Altwiley D, Brignoli T, Edwards A, Recker M, Lee JC et al. A functional menadione biosynthesis pathway is required for capsule production by Staphylococcus aureus. Microbiology 2021; 167:11 [View Article]
    [Google Scholar]
21. Fozo EM, Rucks EA. The making and taking of lipids: the role of bacterial lipid synthesis and the harnessing of host lipids in bacterial pathogenesis. Adv Microb Physiol 2016; 69:51–155 [View Article] [PubMed]
    [Google Scholar]
22. Krsta D, Ku C, Crosby IT, Capuano B, Manallack DT. Bacterial fatty acid synthesis: effect of tween 80 on antibiotic potency against Streptococcus agalactiae and methicillin-resistant Staphylococcus Aureus. Anti-Infective Agents 2014; 12:80–84 [View Article]
    [Google Scholar]
23. Davis MPA, van Dongen S, Abreu-Goodger C, Bartonicek N, Enright AJ. Kraken: a set of tools for quality control and analysis of high-throughput sequence data. Methods 2013; 63:41–49 [View Article]
    [Google Scholar]
24. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012; 19:455–477 [View Article]
    [Google Scholar]
25. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol 2008; 190:300–310 [View Article]
    [Google Scholar]
26. Corrigan RM, Foster TJ. An improved tetracycline-inducible expression vector for Staphylococcus aureus. Plasmid 2009; 61:126–129 [View Article]
    [Google Scholar]
27. Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ et al. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio 2013; 4:e00537-12 [View Article]
    [Google Scholar]
28. Krausz KL, Bose JL. Bacteriophage transduction in Staphylococcus aureus: broth-based method. Methods Mol Biol 2016; 1373:63–68 [View Article] [PubMed]
    [Google Scholar]
29. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9:671–675 [View Article] [PubMed]
    [Google Scholar]
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402–408 [View Article] [PubMed]
    [Google Scholar]
31. Joo H-S, Otto M. The isolation and analysis of phenol-soluble modulins of Staphylococcus epidermidis. Methods Mol Biol 2014; 1106:93–100 [View Article]
    [Google Scholar]
32. Desbois AP, Coote PJJ. Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents. J Antimicrob Chemother 2011; 66:1785–1790 [View Article] [PubMed]
    [Google Scholar]
33. Brignoli T, Douglas E, Duggan S, Fagunloye OG, Adhikari R et al. Wall teichoic acids facilitate the release of toxins from the surface of Staphylococcus aureus. Microbiol Spectr 2022; 10:e0101122 [View Article] [PubMed]
    [Google Scholar]